SANDMAN PAUL W 4/A
4/A · PDL BIOPHARMA, INC. · Filed Apr 13, 2009
Insider Transaction Report
Form 4/AAmended
SANDMAN PAUL W
Director
Transactions
- Purchase
Common Stock
2009-04-08$7.38/sh+10,000$73,822→ 10,000 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.35 to $7.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The filing of this Form 4/A is to correct the Amount of Common Stock Beneficially Owned Following Reported Transaction filed on Form 4 on April 9, 2009. The correct Amount of Common Stock Beneficially Owned Following Reported Transaction is 10,000.